Search...
The concept of innovative drugs has repeatedly strengthened, with Lummy and other stocks hitting the daily limit
The innovative drug concept has recently strengthened repeatedly, with Lummy hitting a 20% limit up. Previously, JLPC and Konruns also hit the limit up, Yahuang Pharmaceutical rose over 15%, and BrightGene, Guanhao Biological, Taloph, and others all rose over 5%
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments